{"transactions":[{"id":2263096,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":127121,"kind":"person","name":"Yu Li","position":1,"cik":"0001777275","reported_name":"Yu Li","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Cntrllr/Prncpl Acctng Offcr"}}],"security":"Restricted Stock Units","published_at":"2022-05-19T21:58:59.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on May 18, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on May 18, 2022."}],"balance_after":25000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-014518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222014518/ownership.xml","form_type":"4"}},{"id":2263095,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":127121,"kind":"person","name":"Yu Li","position":1,"cik":"0001777275","reported_name":"Yu Li","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Cntrllr/Prncpl Acctng Offcr"}}],"security":"Common Stock, no par value","published_at":"2022-05-19T21:58:59.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":8128,"price":1.14,"value":9265.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to cover the tax liability arising from the vesting of Restricted Stock Units."}],"balance_after":16872,"source":{"system":"sec-edgar","filing":"0001493152-22-014518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222014518/ownership.xml","form_type":"4"}},{"id":2263094,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":127121,"kind":"person","name":"Yu Li","position":1,"cik":"0001777275","reported_name":"Yu Li","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Cntrllr/Prncpl Acctng Offcr"}}],"security":"Common Stock, no par value","published_at":"2022-05-19T21:58:59.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-22-014518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222014518/ownership.xml","form_type":"4"}},{"id":2326220,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":127121,"kind":"person","name":"Yu Li","position":1,"cik":"0001777275","reported_name":"Yu Li","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Cntrllr/Prncpl Acctng Offcr"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-18T01:29:52.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest subject to the Issuer's achievement of pre-defined product development, regulatory and financial goals in 2022. 100% of the options will vest on December 31, 2023, if such pre-defined goals have been achieved in 2022, subject to continuous service through the vesting date."}],"balance_after":37500,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001493152-22-007210","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222007210/ownership.xml","form_type":"4"}},{"id":2326219,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":127121,"kind":"person","name":"Yu Li","position":1,"cik":"0001777275","reported_name":"Yu Li","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Cntrllr/Prncpl Acctng Offcr"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-18T01:29:52.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":37500,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001493152-22-007210","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315222007210/ownership.xml","form_type":"4"}},{"id":2542160,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":127121,"kind":"person","name":"Yu Li","position":1,"cik":"0001777275","reported_name":"Yu Li","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Cntrllr/Prncpl Acctng Offcr"}}],"security":"Option to Purchase Common Stock","published_at":"2021-10-14T20:05:25.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option award was granted on May 18, 2021, but such award was subject to shareholder approval of an increase in the number of shares available for issuance under the Oncocyte 2018 Equity Incentive Plan. Such shareholder approval was received on June 24, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will become exercisable after one year of continuous employment from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continued employment on the applicable vesting date."}],"balance_after":160000,"derivative":{"exercise_price":4.33,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-21-025423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315221025423/ownership.xml","form_type":"4"}}]}